Evaluation of antitumor activity of rubomycin deposited in absorbable polymeric microparticles
- 1 March 2008
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 145 (3) , 358-361
Abstract
An experimental dosage form of rubomycin is developed: the drug is incorporated in absorbable polymeric (polyhydroxybutyrate) matrix in the form of microparticles. Antitumor efficiency of this rubomycin dosage form was studied in laboratory mice with transplanted Ehrlich ascitic carcinoma. Rubomycin deposited in polymeric microparticles exhibited pronounced antitumor activity, inhibited the proliferative activity of Ehrlich ascitic carcinoma, and improved survival of mice with tumors. This dosage form of the drug can be used for local injections.Keywords
This publication has 8 references indexed in Scilit:
- Structural optimization of a “smart” doxorubicin–polypeptide conjugate for thermally targeted delivery to solid tumorsJournal of Controlled Release, 2006
- Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(d,l-lactide-co-glycolide) with varying compositionsBiomaterials, 2005
- In vitro study of anticancer drug doxorubicin in PLGA-based microparticlesBiomaterials, 2005
- Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJournal of Controlled Release, 2005
- Pulsed polymersNature Materials, 2003
- Kinetics of ultrasonic release of doxorubicin from pluronic P105 micellesColloids and Surfaces B: Biointerfaces, 2002
- Responsive polymeric delivery systemsAdvanced Drug Delivery Reviews, 2001
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999